| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $90.2M | -19.9% |
| Cost of Revenue | $37.2M | -31.8% |
| R&D Expense | $232.3M | -4.2% |
| SG&A Expense | $88.5M | +3.8% |
| Operating Income | -$268.1M | -2.0% |
| Interest Expense | $6.9M | -70.5% |
| Pre-tax Income | -$263.6M | +6.0% |
| Income Tax | -$152K | -81.0% |
| Net Income | -$263.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.5M | -64.4% |
| Short-term Investments | $240.7M | -10.1% |
| Accounts Receivable | $24.8M | -11.7% |
| Current Assets | $335.0M | -19.5% |
| Total Assets | $574.0M | -31.1% |
| Current Liabilities | $130.3M | -0.1% |
| Total Liabilities | $262.2M | -17.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$218.4M | -5.3% |
| Capital Expenditures | $10.0M | -67.6% |
| Investing Cash Flow | $190.9M | +1700.7% |
| Financing Cash Flow | -$35.0M | -21.2% |
| Free Cash Flow | -$228.4M | +4.1% |
| +6.0% |
| EPS (Basic) | -$6.02 | +7.4% |
| EPS (Diluted) | -$6.02 | +7.4% |
| Stockholders' Equity |
| $311.7M |
| -39.6% |